Wat wij doen
Nieuws
European Commission Grants Marketing Authorisation for SIILTIBCY® – A Novel Tuberculosis Skin Test in Europe
SIILTIBCY® is a tuberculosis skin test approved in European Union that detects tuberculosis infection regardless of BCG vaccination status with demonstrated sensitivity and specificity.
Lees verder
Nieuws
Bilthoven Biologicals opent faciliteiten voor vaccins ter voorbereiding op pandemieën |
Nieuws
VACSERA and Bilthoven Biologicals sign for polio vaccine manufacturing technology |
Nieuws
SLS Europe and Bilthoven Biologicals receive positive CHMP Opinion for SIILTIBCY® - a novel Tuberculosis Skin Test |
